Argenta Ltd is the world's only combined contract research organisation (CRO) and contract manufacturing organisation (CMO) specialising in animal health. With operations and facilities across New Zealand, the USA and the UK, the company develops and exports products and services to over 40 countries.
Argenta, founded in 2006, is dedicated to improving the health of animals worldwide and offers a full range of contract services from pre-clinical development through to commercial product manufacture and more.
Everything is targeted to the specific needs of the animal health market – from the understanding of the problem, the approach to the solution, and the provision of manufactured products once commercialised.
Argenta is equipped to take on entire projects from start to finish, or provide specific services that complement an organisation’s in-house services.
"We opened a manufacturing base in Dundee, Scotland in early 2017 to complement and support our R&D capabilities and operations in New Zealand and the US.
To meet the needs of our ever-expanding global client portfolio, we have increased our presence in Scotland with a new office at Roslin Innovation Centre, located at the gateway to Easter Bush Campus with the largest concentration of animal science related expertise in Europe."
With a global presence, Argenta has the R&D capabilities and manufacturing scale to service a broad range of clients, from large animal health multinationals through to emerging biotech and life sciences companies, helping them to find solutions and take an idea from concept right through to commercial product.
The combination of a successful pharmaceutical CRO and CMO brings innovation, R&D and manufacturing expertise together in one dynamic company. This makes Argenta ideally placed to accommodate unique product requirements no matter the scale or complexity.
R&D clients benefit from a depth of institutional knowledge, resulting in cost efficiencies and smarter product development solutions.
With three state-of-the-art, GMP-compliant manufacturing facilities, Argenta produce a broad scope of successful products for clients— from small volume companion animal products to larger volume livestock products.
Operating around the world, the company provide global market distribution solutions in more than 40 countries and have a competitive global purchasing power.
Independent research for the development of novel drug delivery systems and products for animal health is carried out to protect new products and extend the patent life and exclusivity of existing products.
An extensive intellectual property (IP) portfolio of innovative drug delivery technologies can be tailored to new therapeutics, or for lifecycle management requirements where improved product performance and end-user compliance is key.